Abstract
Cutaneous toxicity following CAR-T therapy is closely linked to immune-cell subset expansion and cytokine dynamics. Prophylactic H1-antihistamines showed effective prevention of rash development, thereby improving the safety profile in solid tumour CAR-T therapy.
Funding Information
  • Taishan Scholar Foundation of Shandong Province (tsqn202312378)
  • National Natural Science Foundation of China (81972793)
  • National Natural Science Foundation of China (81803400)